Abstract
Percutaneous vertebroplasty is a minimally invasive procedure that is effective in the treatment of pain resulting from pathologic compression fractures, osteolytic bone metastases from solid tumors, myeloma, vertebral hemangioma, and osteoporotic compression fractures. A discussion of a patient with severe, aggressive metastatic breast cancer to the spine with compression and osteolysis of multiple lumbar vertebral bodies is presented. Despite treatment with opiates, chemotherapy, radiation therapy, and the implantation of a morphine pump, her pain was not adequately treated until she underwent multilevel vertebroplasty. The clinical and technical application of vertebroplasty in the context of the management of vertebral pain of malignant origin is presented as an integral part of multidisciplinary pain management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
Deramond H, Depriester C, Galibert P, Le Gars D: Percutaneous vertebroplasty with polymethylmethacrylate: technique, indications, and results. Radiol Clin North Am 1998, 36:533–546.
Lin DD, Gailloud P, Murphy KJ: Percutaneous vertebroplasty in benign and malignant disease. Neurosurg Q 2001, 11:290–301. This is a recent comprehensive review and discussion on vertebroplasty for osteoporosis, hemangioma, and metastatic spine disease.
Weill A, Chiras J, Simon JM, et al.: Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996, 199:241–247.
Cotton A, Dewatre F, Cortet B, et al.: Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology 1996, 200:525–530.
Schachar NS: An update on the nonoperative treatment of patients with metastatic bone disease. Clin Orthop 2001, 382:75–81.
Diener KM: Bisphosphonate for controlling pain from metastatic bone disease. Am J Health Syst Pharm 1996, 53:1917–1927.
Meijer NG, van der Veer E, Willemse PH: Biochemical parameter of bone metabolism in bone metastases of solid tumors. Oncol Rep 1998, 5:5–21.
Strallmeyer M, Zoarsky G: Causes of painful compression fractures. In Vertebroplasty [book on CD-ROM]. Edited by Zoarsky GH, Ortiz AO. Ontario: OZ TECH Computers Inc; 2000.
Maynard AS, Jensen ME, Schweickert PA, et al.: Value of bone scan imaging in predicting pain relief from percutaneous vertebroplasty in osteoporotic vertebral fractures. Am J Neuroradiol 2000, 21:1807–1812. Discusses the benefits of using a bone scan to treat chronic vertebral fracture pain up to 6 months after the fracture.
Burr J: Malignant lesion with extensive osteolysis. In Verebroplasty [book on CD-ROM]. Edited by Zoarsky GH, Ortiz AO. Toronto: OZ TECH Computers Inc; 2000. Commentary on the treatment and special considerations of metastatic lesions to the spine.
Tohmeh AG, Mathis JM, Fenton DC, et al.: Biomechanical efficacy of unipedicular versus bipedicular vertebroplasty for the management of osteoporotic compression fractures. Spine 1999, 24:1772–1776.
Liebschner MA, Rosenberg WS, Keaveny TM: Effects of bone cement volume and distribution on vertebral stiffness after vertebroplasty. Spine 2001, 26:1547–1554.
Dion J: Pitfalls and Complications in Vertebroplasty [book on CD-ROM]. Edited by Zoarsky GH, Ortiz. Ontario: OZ TECH Computers Inc; 2000.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dunn, J. Percutaneous vertebroplasty in the management of a patient with malignant pain and associated osteolytic compression fractures. Current Science Inc 6, 436–443 (2002). https://doi.org/10.1007/s11916-002-0062-1
Issue Date:
DOI: https://doi.org/10.1007/s11916-002-0062-1